C33H36BrN9O6 — CID 153306469
(1R,18S,20R)-19-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)pyrazolo[3,4-c]pyridin-1-yl]acetyl]-13-bromo-5,6-dihydroxy-3-methyl-8-oxa-3,14,16,19-tetrazatetracyclo[16.3.1.01,20.010,15]docosa-10(15),11,13-trien-17-one (PubChem CID 153306469) has the molecular formula C33H36BrN9O6 and a molecular weight of 734.61 g/mol. Its IUPAC name is (1R,18S,20R)-19-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)pyrazolo[3,4-c]pyridin-1-yl]acetyl]-13-bromo-5,6-dihydroxy-3-methyl-8-oxa-3,14,16,19-tetrazatetracyclo[16.3.1.01,20.010,15]docosa-10(15),11,13-trien-17-one.
| Compound Name | (1R,18S,20R)-19-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)pyrazolo[3,4-c]pyridin-1-yl]acetyl]-13-bromo-5,6-dihydroxy-3-methyl-8-oxa-3,14,16,19-tetrazatetracyclo[16.3.1.01,20.010,15]docosa-10(15),11,13-trien-17-one |
|---|---|
| PubChem CID | 153306469 |
| Molecular Formula | C33H36BrN9O6 |
| Molecular Weight | 734.61 g/mol |
| Exact Mass | 733.20 |
| IUPAC Name | (1R,18S,20R)-19-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)pyrazolo[3,4-c]pyridin-1-yl]acetyl]-13-bromo-5,6-dihydroxy-3-methyl-8-oxa-3,14,16,19-tetrazatetracyclo[16.3.1.01,20.010,15]docosa-10(15),11,13-trien-17-one |
| SMILES | CC(=O)c1nn(CC(=O)N2[C@H]3C[C@]4(C[C@@H]24)CN(C)CC(O)C(O)COCc2ccc(Br)nc2NC3=O)c2cnc(-c3cnc(C)nc3)cc12 |
| InChI | InChI=1S/C33H36BrN9O6/c1-17(44)30-21-6-22(20-9-35-18(2)36-10-20)37-11-24(21)42(40-30)13-29(47)43-23-7-33(8-27(33)43)16-41(3)12-25(45)26(46)15-49-14-19-4-5-28(34)38-31(19)39-32(23)48/h4-6,9-11,23,25-27,45-46H,7-8,12-16H2,1-3H3,(H,38,39,48)/t23-,25?,26?,27+,33-/m0/s1 |
| InChIKey | JPMCMPSDGZCAJV-ATVOYNQJSA-N |
| XLogP | 1.74 |
| TPSA | 188.79 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 49 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 734.61 |
| LogP ≤ 5 | 1.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|